Biolife Solutions (BLFS) Current Assets (2010 - 2026)

Biolife Solutions (BLFS) has reported Current Assets for 17 consecutive years, with $135.2 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Current Assets rose 7.79% year-over-year to $135.2 million in Q2 2026; TTM through Jun 2026 was $135.2 million, a 7.79% increase from a year earlier, with the FY2025 full-year figure at $136.6 million, down 8.2% from the prior year.
• Current Assets was $135.2 million for Q2 2026 at Biolife Solutions, up from $133.2 million in the prior quarter.
• Over five years, Current Assets peaked at $148.8 million in Q4 2024 and troughed at $88.2 million in Q2 2024.
• A 5-year average of $123.8 million and a median of $126.0 million in 2025 frame the typical range for Current Assets.
• Across the five-year window, Current Assets retreated 26.69% in 2024 and soared 42.21% in 2025, its largest moves.
• Over 5 years, Current Assets stood at $138.5 million in 2022, then retreated by 12.89% to $120.6 million in 2023, then grew by 23.35% to $148.8 million in 2024, then declined by 8.2% to $136.6 million in 2025, then retreated by 1.0% to $135.2 million in 2026.
• The last three Current Assets figures came in at $135.2 million (Q2 2026), $133.2 million (Q1 2026), and $136.6 million (Q4 2025), per Business Quant data.